News & Insights

News and media coverage, company updates, and research and publications from Nexus Intelligence and Nexus AI CXR.

News & Media

External articles, media coverage and selected LinkedIn posts where Nexus and our work are featured. Each item links to the full original publication.

Company Updates

Partnerships, regulatory milestones, events and other news from Nexus Intelligence. Field deployments are written up in full on the Case Studies page.

Recognition

Named by Google: Nexus Intelligence in James Manyika's blog, shared by Sundar Pichai

Google's blog names Nexus Intelligence in its health section: 25,000+ x-rays screened across 40 locations in six nations.

Continue reading →
Cloud services

One cloud, one queue: central radiology reporting with CloudX and Nexus AI CXR

Imaging is captured where there is no radiologist. CloudX is the queue in between, with AI-only, radiologist-only or hybrid reporting in the cloud.

Continue reading →
Partnerships · Event

Nexus Intelligence on the keynote stage at Google Cloud Summit Africa

Watch James Manyika present Nexus Intelligence from the keynote stage, and read about the agreement with Google LLC behind it.

Watch & read →
Regulatory milestone

Nexus AI achieves CE MDR Class IIb certification

What CE MDR Class IIb means for the product, for procurement and for the patients we serve.

Continue reading →

Research & Publications

Clinical, technical and research-focused content, and peer-reviewed publications relating to Nexus AI and our work.

Peer-reviewed publication

Computer-aided detection of tuberculosis from chest radiographs in a TB prevalence survey in South Africa

The Stop TB Partnership's independent evaluation of 12 CAD products. Nexus AI CXR: AUC 0.897, second-highest of twelve, and the highest sensitivity at the fixed operating threshold.

Read in The Lancet ↗
Clinical innovation

Beyond imaging: integrating LLMs into the radiology workflow

How large language models extend chest X-ray triage with context-aware summaries, and why Nexus is keeping it firmly in Beta.

Continue reading →
Product research

Multi-Pathology Beta: where transparency meets innovation

Advancing beyond TB: the multi-pathology layer in Beta, what is in the regulatory pipeline, and how customers can responsibly evaluate it.

Read the approach →